Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical (ISRG) Stock Price & Market Analysis
ISRG · NASDAQ · Medical Instruments & Supplies
$414.79
▲ +$9.61(+2.37%)4:00 PM ET - vs previous closeQuote as of Sep 28, 2026, 4:00 PM EDT
NASDAQ market is closed. Showing the latest available regular-session trade from Sep 28, 2026, 4:00 PM EDT.
Yahoo Finance · latest regular-session print · as of Sep 28, 2026, 4:00 PM EDT · delay not stated · current source
Long-term rangesSince first printHide
Loading price chart…
Session market context
- ISRGStock · vs previous close
- ↑ +2.37%
- QQQNasdaq-100 ETF
- ↓ -1.07%
ISRG outperformed the sector by 3.44 percentage points.
Price comparisons describe market context; they do not establish the cause of a move.
Data freshness
PriceAt closeLast traded
Fundamentalsevery 1 hrProvider checked
Analystevery 12 hrProvider checked
NewsTECHi refresh every 15 minLatest item
Loading upcoming events…
Reported fundamentals
ISRG research snapshot
Annual revenue
USD 10.06B
Sales reported for this fiscal year.
Revenue change
+20.5%
Compared with the prior fiscal year.
Net profit margin
28.4%
Reported net income divided by revenue.
These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.
Company · Profile
About Intuitive Surgical (ISRG)
Sector, leadership, and how Intuitive Surgical earns its revenue.
Healthcare
Company · Profile
About Intuitive Surgical (ISRG)
Sector, leadership, and how Intuitive Surgical earns its revenue.
Intuitive Surgical
NASDAQ · ISRG · US
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Sunnyvale, CA, United States
- Country
- US
- Founded
- 2000
- Employees
- 17,021
- CEO
- Mr. David J. RosaCompany leadership source
- Exchange
- NASDAQ
Business model & operating evidence
AI business exposure
- Revenue exposure
- AI-specific revenue is not separated in the available company statements.
- Capital-spending dependency
- No reviewed quantitative dependency model is available.
- Compute role
- See the sourced business description; AI labels do not establish compute revenue.
- Platform examples
- An exhaustive, consistently defined product inventory is unavailable.
- Ecosystem links
- Supplier and customer links require reviewed disclosures.
Narrative versus numbers
Demand is expanding
Supporting observation: 18.5%
Quarterly revenue growth year over year; company-wide, not exclusively AI. · TECHi unified data · 2026-06-30
Growth produces accounting profit
Supporting observation: 28.4%
Net margin. A positive figure supports profitability, not necessarily cash generation. · SEC Companyfacts · 2026-09-29T09:19:37.671Z
The business generates cash after investment
Supporting observation: 948.4M
Latest available free cash flow; period-specific, not a forecast. · SEC Companyfacts · 2026-06-30
These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.
Operating measures
- Revenue
- $2.89Bquarter ended Jun 30, 2026
- Gross margin
- 67.8%quarter ended Jun 30, 2026
- Operating margin
- 33.6%quarter ended Jun 30, 2026
- EPS
- $2.29quarter ended Jun 30, 2026
- Capital expenditure
- $112.60Mquarter ended Jun 30, 2026
- Free cash flow
- $948.40Mquarter ended Jun 30, 2026
- Free cash flow margin
- 32.8%quarter ended Jun 30, 2026
- Operating cash / net income
- 1.30×quarter ended Jun 30, 2026
- Revenue growth year over year
- 18.5%quarter ended Jun 30, 2026
Leadership
CEO: Mr. David J. Rosa
Source: Yahoo Finance · 2026-09-29T10:18:13.293Z
Ownership filings and insider activityCompetitors & comparisons
Loading competitor research…
Loading fund exposure…
Governance & sustainability
Dated environmental and governance disclosures are not available in this dataset. TECHi does not infer an ESG rating from profitability, volatility, headcount or executive biographies.
All data sources
Search the dated figures used for this view. Each entry identifies its units, reporting period and calculation status.
US market hours
Regular hours: 9:30 AM–4:00 PM America/New_York
Next open: Checking…
Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.
Shortcuts
/ search · W watchlist · C compare · F financials · E earnings · N news · T technicals · Esc close
